Skip to content

MRSA POC trial

A trial of a rapid point of care (POC) method of MRSA detection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN35178384
Enrollment
10000
Registered
2014-07-31
Start date
2011-05-03
Completion date
Unknown
Last updated
2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRSA infection Infections and Infestations

Interventions

Control group: When each patient is admitted to and discharged from the ward, nursing staff will take a set of MRSA screening swabs. MRSA screening on admission is already in practice at King's Colleg

Sponsors

Guy's & St Thomas' NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All adult admissions to study wards who are screened within 48 hours of admission to and discharge from the study wards are eligible for inclusion.

Exclusion criteria

Exclusion criteria: Patients who are: 1. MRSA positive on any specimens taken up to 5 days before the current admission 2. MRSA culture positive on study ward MRSA admission screen 3. Are not swabbed for MRSA on admission 4. Have MRSA admission screening swabs taken >48 hours after study ward admission 5. MRSA discharge screens which do not contain nose, throat and groin or perineum swabs 6. Are not swabbed for MRSA on discharge

Design outcomes

Primary

MeasureTime frame
MRSA transmission rates = the ratio of patients who are positive for MRSA by conventional microbiological method at the time of admission to the number of patients who are negative for MRSA on admission screens by conventional microbiological method and subsequently become positive by discharge on any specimen taken >48 hours after admission. The primary outcome will be analysed using generalised estimating equations with Poisson family, log link and robust standard errors will be used to fully account for correlations of observations made within wards, periods and ward periods.

Secondary

MeasureTime frame
1. Appropriate and inappropriate isolation days 2. MRSA carriage rate and acquisition rate Secondary outcomes will be measured after one month.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026